Study of the vasodilatory effect of extract from tissue culture biomass of Rauwolfia serpentina Benth.
Design of novel herbal drugs with a wide range of activity is an important object of pharmacology. Herbal remedies having antiarrhythmic, cardiotonic and vasodilatory effects are useful for treatment of heart arrhythmias. Vasodilating drugs are prescribed for medication of hypertension and migraine. Also they are a part of comprehensive treatment of various diseases such as disturbed peripheral blood circulation and atherosclerosis of arteries of extremities as well as problems with urination and potency. Search for novel herbal preparations with vasorelaxant activity in our view is a promising matter of current interest.
This work is aiming in study of vasodilatory activity of methanol extract of strain K-27 tissue culture of Rauwolfia serpentina.
Evaluation of vasodilatory activity extract of high-productive strain K-27 tissue culture of Rauwolfia serpentina has been carried out by the method of auxotonic mechanography of vascular smooth muscles. Strength and frequency of spontaneous contractions of portal vein as well as relaxation of aortic smooth muscles activated with phenylephrine were evaluation indicators of extract activity.
In order to estimate working concentration of extract of strain K-27 tissue culture of Rauwolfia serpentina we have studied vascular activity at sequentially increasing concentrations of extract solution on the portal vein. Overlay of sequence of growing concentrations exhibited decrease in basal level of venous tone and dose-dependent suppression of phasic contractions with complete inhibition of spontaneous activity of portal vein at 1.44 mg/ml concentration and uprise of toxicity at higher concentrations. It has been shown dose-dependent relaxation of vascular preparations followed by development of α-adrenoceptor blocking effect and loss of sensibility to phenylephrine at the end of experiment. After discontinuing exposure with a substance the activating effect of phenylephrine remained not renewed during 30-50 minutes, at the same time contractile activity of aorta on the response to the other type activation (60 mM K+) took place.
It was found that at the studied range of concentrations: 0.0288 μg/ml–28.8 μg/ml the extract of strain K-27 tissue culture of Rauwolfia serpentina has distinct vasodilatory effect. Also it was discovered α-adrenoceptor blocking effect of that extract, so it can find wide application in therapy as vasorelaxant and α-blocker, for instance in treatment of prostate diseases.
Minarchenko V. M., Butko A. Yu. Doslidzhennia vitchyznianoho rynku likarskykh zasobiv // Farmats. zhurn. – 2017. – № 1. – S. 30–36.
Poonam Agrawal Sh., Mishra S. Physiological, biochemical and modern biotechnological approach to improvement of Rauwolfia serpentina // IOSR – J. Pharmacy Biol. Sci. – 2013. – V. 6, N 2. – P. 73–78.
Lobay D. Rauwolfia in the Treatment of Hypertension // Integrative Med. – 2015. – V. 14, N 3. – P. 40–46.
Singh M., Kaur R., Rajput R., Mathur G. Evaluating the therapeutic efficiency and drug targeting ability of alkaloids present in Rauwolfia serpentina // Inter. J. Green Pharmacy. – 2017. – V. 11, N 3. – P. 132–142.
Shamon S. D., Perez M. I. Blood pressure-lowering efficacy of reserpine for primary hypertension // Cochrane Database Syst. Rev. – 2016. – CD007655. https://doi.org/10.1002/14651858
Morales A. Yohimbine in erectile dysfunction: the facts // Int. J. Impot. Res. 2000. – P. 70–74.
Cimolai N., Cimolai T. Yohimbine use for physical enhancement and its potential toxicity // J. Dietary Suppl. – 2011. – V. 8, Iss. 4. – P. 346–354. https://doi.org/10.3109/19390211.2011.615806
Kunakh V. A. Biotekhnolohiia likarskykh roslyn. Henetychni ta fizioloho-biokhimichni osnovy. Monohrafiia. – K.: Lohos, 2005. – 730 s.
Mukherjee E., Gantait S., Kundu S. et al. Biotechnological interventions on the genus Rauvolfia: recent trends and imminent prospects // Appl. Microbiol. Biotechnol. – 2019. – V. 103. – P. 7325–7354. https://doi.org/10.1007/s00253-019-10035-6
Samuels S. S. The vasodilating action of Rauwolfia serpentina // Angiology. – 1956. – V. 7, N 1. – P. 86–87.
Lowe F. C. Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms // Clin Ther. – 2004. – V. 11. – P. 1701–1713. https://doi.org/10.1016/j.clinthera.2004.11.006
Kalsi J., Muneer A. Erectile dysfunction - an update of current practice and future strategies // J. Clin. Urol. – 2013. – V. 6, N 4. – P. 210–219. https://doi.org/10.1177/2051415813491862
Shah S. M. A., Naqvi S. A. R., Munir N. et al. Antihypertensive and antihyperlipidemic activity of aqueous methanolic extract of Rauwolfia serpentina in albino rats // Dose Response. – 2020. – V. 18, N 3. https://doi.org/10.1177/1559325820942077
Koloko B. L., Bushra I., Wankeu-Nya M. et al. In vivo effects of Rauvolfia vomitoria (Apocynaceae) ethanolic extract on sexual performance and reproductive activity in male rats // Andrologia. – 2020. – V. 52, N 1. – P. e13414. https://doi.org/10.1111/and.13414
This work is licensed under a Creative Commons Attribution 4.0 International License.